Preoperative cardiovascular evaluation for noncardiac surgery

Mount Sinai Journal of Medicine

Volumn 72, Issue 3, 2005, Pages 185-192

  Maddox, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery bypass grafting; Coronary artery disease; Intra operative complications; Percutaneous coronary intervention; Perioperative care; Postoperative complications; Risk assessment; Risk factors; Surgical procedures

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIVAZEROL; NITRATE;

ABDOMINAL SURGERY; ANGIOPLASTY; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DIABETES MELLITUS; ELECTIVE SURGERY; EXERCISE TOLERANCE; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FAILURE; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; STABLE ANGINA PECTORIS; STRESS ECHOCARDIOGRAPHY; SURGICAL RISK; SURGICAL TECHNIQUE; THORAX SURGERY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS; VASCULAR SURGERY;

CARDIOVASCULAR DISEASES; COMORBIDITY; DIAGNOSTIC TESTS, ROUTINE; HUMANS; PATIENT CARE PLANNING; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 18744396073     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Grayburn PA, Hillis LD. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 2003; 138:506-511.
2. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
3. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341:1789-1794.
4. Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001; 345(23):1677-1682.
5. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39(3):542-553.
6. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845-850.
7. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1:211-219.
8. Reilly DF, McNeely MJ, Doerner D, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 159:2185-2192.
9. Wohrle J, Al-Khayer E, Grotzinger U, et al. Comparison of the heparin coated vs the uncoated Jostent - no influence on restenosis or clinical outcome. Eur Heart J 2001; 22(19):1808-1816.
10. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118:504-510.
11. Goldman L. Cardiac risks and complications of noncardiac surgery. Ann Intern Med 1983; 98:504-513.
12. Plecha FR, Bertin VJ, Plecha EJ, et al. The early results of vascular surgery in patients 75 years of age and older: an analysis of 3259 cases. J Vasc Surg 1985; 2:769-774.
13. Greenburg AG, Saik RP, Pridham D. Influence of age on mortality of colon surgery. Am J Surg 1985; 150:65-70.
14. Backer CL, Tinker JH, Robertson DM, Vlietstra RE. Myocardial reinfarction following local anesthesia for ophthalmic surgery. Anesth Analg 1980; 59:257-262.
15. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72:153-184.
16. Vanzetto G, Machecourt J, Blendea D, et al. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 1996; 77:143-148.
17. Bartels C, Bechtel JF, Hossmann V, Horsch S. Cardiac risk stratification for high-risk vascular surgery. Circulation 1997; 95:2473-2475.
18. Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994; 330:663-669.
19. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285(14):1865-1873.
20. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335:1713-1720.
21. Oliver MF, Goldman L, Julian DG, Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 1999; 91:951-961.
22. [No authors listed.] Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI - Europe Research Group. Anesthesiology 1997; 86(2):346-363.
23. Stuhmeier KD, Mainzer B, Cierpka J, et al. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology 1996; 85:706-712.
24. Dodds TM, Stone JG, Coromilas J, et al. Prophylactic nitroglycerin infusion during noncardiac surgery does not reduce perioperative ischemia. Anesth Analg 1993; 76:705-713.
25. Coriat P, Daloz M, Bousseau D, et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous nitroglycerin. Anesthesiology 1984; 61:193-196.
26. Godet G, Coriat P, Baron JF, et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem: a randomized trial versus placebo. Anesthesiology 1987; 66:241-245.
27. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107:1848-1851.
28. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004; 291:2092-1099.
29. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg 1999; 89:849-855.
30. Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 1997; 96:1882-1887.
31. Mason JJ, Owens DK, Harris RA, et al. The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA 1995; 273:1919-1925.
32. Fleisher LA, Skolnick ED, Holroyd KJ, Lehmann BP. Coronary artery revascularization before abdominal aortic aneurysm surgery: a decision analytic approach. Anesth Analg 1994; 79:661-669.
33. McFalls EO, Ward HB, Krupski WC, et al. Prophylactic coronary artery revascularization for elective vascular surgery: study design. Veterans Affairs Cooperative Study Group on Coronary Artery Revascularization Prophylaxis for Elective Vascular Surgery. Control Clin Trials 1999; 20:297-308.
34. Allen JR, Helling TS, Hartzler GO. Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty. Surg Gynecol Obstet 1991; 173:285-288.
35. Elmore JR, Hallett JW Jr, Gibbons RJ, et al. Myocardial revascularization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty. Mayo Clin Proc 1993; 68:637-641.
36. Gottlieb A, Banoub M, Sprung J, et al. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 1998; 12:501-506.
37. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999; 89:553-560.
38. Landesberg G, Mosseri M, Wolf YG, et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation 2003; 108:177-183.
39. Bergeron P, Rudondy P, Poyen V, et al. Long-term peripheral stent evaluation using angioscopy. Int Angiol 1991; 10(3):182-186.
40. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994; 23:341-346.
41. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42(2):234-240.
42. Bradbury A, Adam D, Garrioch M, et al. Changes in platelet count, coagulation and fibrinogen associated with elective repair of asymptomatic abdominal aortic aneurysm and aortic reconstruction for occlusive disease. Eur J Vasc Endovasc Surg 1997; 13:375-380.
43. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288-1294.
44. Vicenzi MN, Ribitsch D, Luha O, et al. Coronary artery stenting before noncardiac surgery: more threat than safety? Anesthesiology 2001; 94:367-368.
45. Sharma A. Coronary angioplasty with stenting preceding major noncardiac surgery: when is it safe to operate? JACC Abstracts in angiography and interventional cardiology [abstract]. 2003; 20A: 1052-1182.
46. Teirstein P, Reilly JP. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy. J Invasive Cardiol 2002; 14:109-114.
47. Bartorelli AL, Trabattoni D, Montorsi P, et al. Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study. Catheter Cardiovasc Interv 2002; 55:150-156.